Amyloid and tau accumulate across distinct spatial networks and are differentially associated with brain connectivity
暂无分享,去创建一个
Rik Ossenkoppele | Eric Westman | Joana B Pereira | Oskar Hansson | Sebastian Palmqvist | E. Westman | O. Hansson | S. Palmqvist | Ruben Smith | R. Ossenkoppele | T. O. Strandberg | J. Pereira | Ruben Smith | Tor Olof Strandberg
[1] B. Miller,et al. Neurodegenerative Diseases Target Large-Scale Human Brain Networks , 2009, Neuron.
[2] P J Manos,et al. The Ten Point Clock Test: A Quick Screen and Grading Method for Cognitive Impairment in Medical and Surgical Patients , 1994, International journal of psychiatry in medicine.
[3] Henrik Zetterberg,et al. Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity , 2017, Nature Communications.
[4] Cindee M. Madison,et al. Effects of Beta-Amyloid on Resting State Functional Connectivity Within and Between Networks Reflect Known Patterns of Regional Vulnerability. , 2014, Cerebral cortex.
[5] Rik Ossenkoppele,et al. Distinct 18F‐AV‐1451 tau PET retention patterns in early‐ and late‐onset Alzheimer's disease , 2017, Brain : a journal of neurology.
[6] Zeshan Ahmed,et al. A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity , 2014, Acta Neuropathologica.
[7] William J. Jagust,et al. Lifespan brain activity, β-amyloid, and Alzheimer's disease , 2011, Trends in Cognitive Sciences.
[8] Vince D. Calhoun,et al. Neuronal chronometry of target detection: Fusion of hemodynamic and event-related potential data , 2005, NeuroImage.
[9] C. Jack,et al. Alzheimer's Disease Neuroimaging Initiative , 2008 .
[10] William J. Jagust,et al. Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease , 2017, NeuroImage.
[11] Benjamin J. Shannon,et al. Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory , 2005, The Journal of Neuroscience.
[12] Christopher G Schwarz,et al. Regional multimodal relationships between tau, hypometabolism, atrophy, and fractional anisotropy in atypical Alzheimer's disease , 2018, Human brain mapping.
[13] Henrik Zetterberg,et al. 18F‐AV‐1451 and CSF T‐tau and P‐tau as biomarkers in Alzheimer's disease , 2017, EMBO molecular medicine.
[14] Daniel R. Schonhaut,et al. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease. , 2016, Brain : a journal of neurology.
[15] Efstathios D. Gennatas,et al. Predicting Regional Neurodegeneration from the Healthy Brain Functional Connectome , 2012, Neuron.
[16] K. Davis,et al. A new rating scale for Alzheimer's disease. , 1984, The American journal of psychiatry.
[17] Keith A. Johnson,et al. Cortical Hubs Revealed by Intrinsic Functional Connectivity: Mapping, Assessment of Stability, and Relation to Alzheimer's Disease , 2009, The Journal of Neuroscience.
[18] Jorge Sepulcre,et al. Structural tract alterations predict down-stream tau accumulation in amyloid positive older individuals , 2018, Nature Neuroscience.
[19] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[20] R. Mayeux,et al. Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer's disease , 2013, Nature Neuroscience.
[21] Yi Su,et al. Tau and Aβ imaging, CSF measures, and cognition in Alzheimer's disease , 2016, Science Translational Medicine.
[22] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[23] Christopher C Rowe,et al. Tau imaging: early progress and future directions , 2015, The Lancet Neurology.
[24] William J. Jagust,et al. Measurement of Longitudinal β-Amyloid Change with 18F-Florbetapir PET and Standardized Uptake Value Ratios , 2015, The Journal of Nuclear Medicine.
[25] C. Jack,et al. Age-specific population frequencies of cerebral β-amyloidosis and neurodegeneration among people with normal cognitive function aged 50–89 years: a cross-sectional study , 2014, The Lancet Neurology.
[26] C. Jack,et al. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers , 2013, The Lancet Neurology.
[27] Daniel R. Schonhaut,et al. Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer’s disease , 2017, Brain : a journal of neurology.
[28] Rupert Lanzenberger,et al. Modeling Strategies for Quantification of In Vivo 18F-AV-1451 Binding in Patients with Tau Pathology , 2017, The Journal of Nuclear Medicine.
[29] Philip S. Insel,et al. 18 FAV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer ’ s disease , 2017 .
[30] Keith A. Johnson,et al. Tau and amyloid β proteins distinctively associate to functional network changes in the aging brain , 2017, Alzheimer's & Dementia.
[31] C. Sorg,et al. Within-patient correspondence of amyloid-β and intrinsic network connectivity in Alzheimer’s disease , 2014, Alzheimer's & Dementia.
[32] Brian A. Gordon,et al. Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease , 2018, Neurology.
[33] M. Raichle,et al. Resting State Functional Connectivity in Preclinical Alzheimer’s Disease , 2013, Biological Psychiatry.
[34] Keith A. Johnson,et al. Hierarchical Organization of Tau and Amyloid Deposits in the Cerebral Cortex , 2017, JAMA neurology.
[35] Keith A. Johnson,et al. Amyloid Deposition Is Associated with Impaired Default Network Function in Older Persons without Dementia , 2009, Neuron.
[36] Bradford C. Dickerson,et al. Tau PET imaging in aging and early Alzheimer's disease , 2015 .
[37] K. Iqbal,et al. Hyperphosphorylation determines both the spread and the morphology of tau pathology , 2016, Alzheimer's & Dementia.
[38] O. Hansson,et al. Distinct 18 FAV-1451 tau PET retention patterns in early-and late-onset Alzheimer ’ s disease , 2017 .
[39] Mark W. Woolrich,et al. Probabilistic diffusion tractography with multiple fibre orientations: What can we gain? , 2007, NeuroImage.
[40] T. Singh,et al. Tau Pathology , 2019, Advances in Medical Diagnosis, Treatment, and Care.
[41] Michael D. Greicius,et al. Relationships between β-amyloid and functional connectivity in different components of the default mode network in aging. , 2011, Cerebral cortex.
[42] Christian Windischberger,et al. Toward discovery science of human brain function , 2010, Proceedings of the National Academy of Sciences.
[43] Brian A. Gordon,et al. Loss of white matter integrity reflects tau accumulation in Alzheimer disease defined regions , 2018, Neurology.
[44] Hanna Cho,et al. In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum , 2016, Annals of neurology.
[45] Keith A. Johnson,et al. Disruption of Functional Connectivity in Clinically Normal Older Adults Harboring Amyloid Burden , 2009, The Journal of Neuroscience.
[46] Daniel R. Schonhaut,et al. PET Imaging of Tau Deposition in the Aging Human Brain , 2016, Neuron.
[47] D. Y. Lee,et al. Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. , 2015, JAMA.
[48] C. Sorg,et al. Within-patient correspondence of amyloid-β and intrinsic network connectivity in Alzheimer’s disease , 2014, Alzheimer's & Dementia.
[49] Gereon R Fink,et al. NETWORKS OF TAU DISTRIBUTION IN ALZHEIMER’S DISEASE , 2017, Alzheimer's & Dementia.
[50] J. Morrison,et al. Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease , 2003, Neurology.
[51] Keith A. Johnson,et al. Neuronal dysfunction and disconnection of cortical hubs in non-demented subjects with elevated amyloid burden , 2011, Alzheimer's & Dementia.
[52] Keith A. Johnson,et al. In Vivo Tau, Amyloid, and Gray Matter Profiles in the Aging Brain , 2016, The Journal of Neuroscience.
[53] M. Fox,et al. Network localization of heterogeneous neuroimaging findings , 2018, Brain : a journal of neurology.
[54] K. Blennow,et al. Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid β-amyloid 42: a cross-validation study against amyloid positron emission tomography. , 2014, JAMA neurology.
[55] Richard Hollister,et al. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease , 1997, Annals of neurology.
[56] Naruhiko Sahara,et al. Propagation of Tau Pathology in a Model of Early Alzheimer's Disease , 2012, Neuron.
[57] A. Fagan,et al. Evaluation of Tau Imaging in Staging Alzheimer Disease and Revealing Interactions Between β-Amyloid and Tauopathy. , 2016, JAMA neurology.
[58] John Ashburner,et al. A fast diffeomorphic image registration algorithm , 2007, NeuroImage.
[59] Jürgen Götz,et al. Amyloid-β and tau — a toxic pas de deux in Alzheimer's disease , 2011, Nature Reviews Neuroscience.
[60] D. Head,et al. Amyloid Plaques Disrupt Resting State Default Mode Network Connectivity in Cognitively Normal Elderly , 2010, Biological Psychiatry.
[61] K. Blennow,et al. CSF markers for incipient Alzheimer's disease , 2003, The Lancet Neurology.
[62] Clifford R. Jack,et al. Tau, amyloid, and cascading network failure across the Alzheimer's disease spectrum , 2017, Cortex.
[63] H. Braak,et al. The preclinical phase of the pathological process underlying sporadic Alzheimer's disease. , 2015, Brain : a journal of neurology.
[64] Henrik Zetterberg,et al. Comparing 18F-AV-1451 with CSF t-tau and p-tau for diagnosis of Alzheimer disease , 2018, Neurology.
[65] Tülay Adali,et al. Estimating the number of independent components for functional magnetic resonance imaging data , 2007, Human brain mapping.
[66] H. Braak,et al. Phases of Aβ-deposition in the human brain and its relevance for the development of AD , 2002, Neurology.
[67] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[68] Hanna Cho,et al. Tau PET in Alzheimer disease and mild cognitive impairment , 2016, Neurology.
[69] H. Braak,et al. Evolution of neuronal changes in the course of Alzheimer's disease. , 1998, Journal of neural transmission. Supplementum.
[70] O. Hansson,et al. Tau Pathology Distribution in Alzheimer's disease Corresponds Differentially to Cognition-Relevant Functional Brain Networks , 2017, Frontiers in Neuroscience.
[71] J. Schneider,et al. National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease , 2012, Alzheimer's & Dementia.
[72] C. Jack,et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade , 2010, The Lancet Neurology.
[73] Peter A. Calabresi,et al. Tract probability maps in stereotaxic spaces: Analyses of white matter anatomy and tract-specific quantification , 2008, NeuroImage.
[74] C. Jack,et al. Biomarker Modeling of Alzheimer’s Disease , 2013, Neuron.
[75] C. Jack,et al. NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease , 2018, Alzheimer's & Dementia.